A study in the Journal of Clinical Oncology found the number of blood stem cell transplants increased significantly between 1994 and 2005. The researchers reviewed outcomes of about 38,000 patients who underwent the procedure. One hundred days after the transplant, survival rates for patients treated for myeloid leukemias who had a related donor increased from 85% to 94% and survival rates with unrelated donor transplants increased from 63% to 86%. One year after transplant, the survival rate for patients who had an unrelated donor rose from 48% to 63%.

Full Story:

Related Summaries